Meeting Objectives: Pharma/Biotech Project Portfolio Management Summit

Due to the nature of Pharma/Biotech R&D, it is a costly, time-consuming affair, notwithstanding the ever-growing competition and fluctuating environments. Developing drug portfolios demands PPM to be highly innovative, structured and well organised.

Vonlanthen Group of Companies shall be hosting an event to overcome these challenges, through an expert panel of speakers and delegates to discuss, innovate and resolve critical issues for fast track solutions to complex PPM problems.

Key Practical Learning Points of the Summit:

  • Engaging R&D teams to drive product cycles
  • Holistic and transparent approaches through the pipeline
  • Determining the most viable projects
  • Restructuring and reforecasting project portfolios
  • Mastering the role of PPM in internal and external collaborations
  • Maximising PPM tool efficiency and organic interaction
  • Extracting quality data from mass information feeds
  • An in-depth look into mitigating uncertainty

Who Should Attend:

Chief Executives, Directors, Vice Presidents, Department Heads, Leaders and Managers specialising in:

  • Portfolio Management
  • Portfolio Development
  • Portfolio Analysis
  • Portfolio Planning
  • Portfolio Analytics
  • Portfolio Sourcing
  • Project Management
  • Project Planning
  • Program Management
  • Resource Management
  • Capacity Management
  • Strategic Planning
  • Strategy Development
  • R&D Operations
  • Clinical Development
  • Alliance Management
  • Investment Support
  • Decision Support
  • Corporate Strategy
  • Corporate Development
  • Business Development
  • Marketing

From Industries:

  • Pharmaceutical
  • Biotechnology
  • Medical devices
Media partners